Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Hamdy Zawam"'
Autor:
Nesreen Amer Ramadan Aly, Samia Rizk, Azza Aboul Enein, Nermeen El Desoukey, Hamdy Zawam, Manzoor Ahmed, Mohey Eldin El Shikh, Costantino Pitzalis
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundDespite the significant progress in the treatment of multiple myeloma (MM), the disease remains untreatable and its cure is still an unmet clinical need. Neoplastic transformation in MM is initiated in the germinal centers (GCs) of secondar
Externí odkaz:
https://doaj.org/article/7b0ff02fca9b441085f9bb3e5e5e32d3
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Long non-coding RNAs (LncRNAs) have recently been considered promising biomarkers for oncogenesis due to their epigenetic regulatory effects. HOTAIR is one of the oncogenic LncRNAs that was previously studied in different non-hema
Externí odkaz:
https://doaj.org/article/8dd36435531c470aa8c490a76ccfff2d
Publikováno v:
Research in Oncology, Vol 14, Iss 1, Pp 17-20 (2018)
Background: Treatment after failure of 2nd line chemotherapy in patients with Hodgkin's lymphoma (HL) or aggressive non-Hodgkin’s lymphoma (NHL) is not well studied. Aim: To assess the value of 3rd line treatment in a cohort of HL and aggressive NH
Externí odkaz:
https://doaj.org/article/f6daffb6bb8a45e78875fc9f417ac475
Publikováno v:
Research in Oncology, Vol 14, Iss 1, Pp 12-16 (2018)
Background: There is lack of evidence about the best chemotherapy regimen in treatment of relapsed/refractory Hodgkin'slymphoma (HL) and aggressive non-Hodgkin’s lymphoma (NHL) lymphoma.Aim: To compare GEMOX (gemcitabine, oxaliplatin) with ESHAP (e
Externí odkaz:
https://doaj.org/article/e756651f692e491793e845395c7e658d
Publikováno v:
International journal of health sciences. :8810-8821
Background: Diffuse large B-cell lymphoma is a challenging disease in management. Although most patients are cured with the standard R-CHOP, one third of them remains refractory to this regimen. As prognosis of refractory disease is worse than primar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a54a05960b10529c717ef3e80bb8f98c
https://doi.org/10.53730/ijhs.v6ns6.12359
https://doi.org/10.53730/ijhs.v6ns6.12359
Publikováno v:
International Orthopaedics. 46:2127-2134
Purpose To compare the clinical results, complication rates, and radiographic outcome between both methods of fixation of lateral malleolar fractures: lateral neutralization plates and intramedullary fully threaded screws. Patients and methods This p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1cbe4f52d2f69437fb4185e54fb5178
https://doi.org/10.1007/s00264-022-05425-x
https://doi.org/10.1007/s00264-022-05425-x
Publikováno v:
Indian J Hematol Blood Transfus
Polymorphisms in the IL-2 gene are associated with various diseases and cancers including non-Hodgkin lymphoma (NHL). The aim of the study is to assess the impact of IL-2 genetic polymorphisms [− 330 T/G (rs2069762) and + 114 T/G (rs2069763)] on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae9c8d4924e83c5a8995f4d3dab54170
https://doi.org/10.1007/s12288-020-01388-4
https://doi.org/10.1007/s12288-020-01388-4
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 22, Iss 1, Pp 1-9 (2021)
Background Long non-coding RNAs (LncRNAs) have recently been considered promising biomarkers for oncogenesis due to their epigenetic regulatory effects. HOTAIR is one of the oncogenic LncRNAs that was previously studied in different non-hematological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc1f70f1cc0d601f25ca0f0c788aa685
https://doi.org/10.1186/s43042-021-00180-x
https://doi.org/10.1186/s43042-021-00180-x
Publikováno v:
Current Orthopaedic Practice. 30:566-571
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcc7e3add23a4d5fbb6eac56999fb1e0
https://doi.org/10.1097/bco.0000000000000810
https://doi.org/10.1097/bco.0000000000000810
Publikováno v:
Egyptian Journal of Pathology. 38:84-91
Background and aimNon-Hodgkin diffuse large B-cell lymphoma having MYC in addition to BCL2 and/or BCL6 rearrangements was recently defined as double/triple-hit lymphoma. Diagnosis by fluorescence in-situ hybridization is sensitive and specific but is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbff33ba45d1fdfaf76d8573690b6cb5
https://doi.org/10.1097/01.xej.0000542229.76140.d7
https://doi.org/10.1097/01.xej.0000542229.76140.d7